Clinical Trial

Wearable Epileptic Seizure Prediction and Alert Glasses Based on Neuromorphic Computing

Study acronym: WESPG
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 7, 2025 (before its estimated October 20, 2025 completion). Its status may not reflect the trial's current state.
Summary
The NEXA study aims to evaluate a new wearable EEG device designed as smart glasses with dry electrodes positioned according to the 10-20 system. The device captures real-time brain signals to detect patterns that may predict seizures, helping people with epilepsy. This study will test the device's safety, performance, and usability before seeking regulatory approval, including FDA clearance. The NEXA device is investigational and not yet approved by the U.S. FDA. The study will involve human participants who will wear the device while data is collected and analyzed. Results will help improve the device and support future certification for medical use.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-08-17; most recent amendment 2025-10-01.
Trial Details
NCT Number NCT07139457
Lead Sponsor Oman Ministry of Health
Conditions Epilepsy, Epileptic Seizures, Focal Epilepsy
Enrollment 47 participants
Start Date 2025-08-10
Primary Completion 2025-10-20 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-10-07